TY - JOUR
T1 - Anticancer effect of physical activity is mediated by modulation of extracellular microRNA in blood
AU - Pulliero, Alessandra
AU - You, Ming
AU - Chaluvally-Raghavan, Pradeep
AU - Marengo, Barbara
AU - Domenicotti, Cinzia
AU - Banelli, Barbara
AU - Degan, Paolo
AU - Molfetta, Luigi
AU - Gianiorio, Fabio
AU - Izzotti, Alberto
N1 - Funding Information:
This study was partially supported by the Italian Association for Cancer Research (AIRC, IG-2017 Id.20699).
Publisher Copyright:
© 2020 Impact Journals LLC. All rights reserved.
PY - 2020/6/1
Y1 - 2020/6/1
N2 - Epidemiological studies provide evidence that physical activity reduces the risk of cancer, particularly of breast cancer. However, little is known about the underlying molecular mechanisms as related to microRNAs. The goal of the herein presented study is to explore the involvement of miRNAs in beneficial effects exerted by physical activity in breast cancer prevention. Thirty subjects (mean age: 57.1 ± 14.7 years) underwent 45 minutes of treadmill walking under standardized conditions. The levels of extracellular miRNAs were evaluated in blood plasma before and after structured exercise by means of microarray analysis of 1,900 miRNAs identifying mostly modulated miRNAs. Structured exercise has been found to modulate the expression of 14 miRNAs involved in pathways relevant to cancer. The different expression of two miRNAs involved in breast cancer progression, i. e. up-regulation of miR-206 and down-regulation of anti-miR-30c, were the most striking effects induced by exercise. The biological effects of these miRNAs were investigated in MCF-7 human breast cancer cells. miR-206 transfection and anti-miR-30c silencing, inhibited cell growth and increased apoptosis of MCF-7 cells. Moreover, the combined use of the two miRNAs further enhanced apoptosis and induced growth arrest in the G1/S phase of cell cycle. Our results support that physical activity effectively change the expression of extracellular miRNAs. Specifically, miR-206 up-regulation and anti-miR-30c downregulation act as suppressors in breast cancer cells. The evaluation of these miRNAs in blood can be used as non-invasive biomarkers for breast cancer prevention.
AB - Epidemiological studies provide evidence that physical activity reduces the risk of cancer, particularly of breast cancer. However, little is known about the underlying molecular mechanisms as related to microRNAs. The goal of the herein presented study is to explore the involvement of miRNAs in beneficial effects exerted by physical activity in breast cancer prevention. Thirty subjects (mean age: 57.1 ± 14.7 years) underwent 45 minutes of treadmill walking under standardized conditions. The levels of extracellular miRNAs were evaluated in blood plasma before and after structured exercise by means of microarray analysis of 1,900 miRNAs identifying mostly modulated miRNAs. Structured exercise has been found to modulate the expression of 14 miRNAs involved in pathways relevant to cancer. The different expression of two miRNAs involved in breast cancer progression, i. e. up-regulation of miR-206 and down-regulation of anti-miR-30c, were the most striking effects induced by exercise. The biological effects of these miRNAs were investigated in MCF-7 human breast cancer cells. miR-206 transfection and anti-miR-30c silencing, inhibited cell growth and increased apoptosis of MCF-7 cells. Moreover, the combined use of the two miRNAs further enhanced apoptosis and induced growth arrest in the G1/S phase of cell cycle. Our results support that physical activity effectively change the expression of extracellular miRNAs. Specifically, miR-206 up-regulation and anti-miR-30c downregulation act as suppressors in breast cancer cells. The evaluation of these miRNAs in blood can be used as non-invasive biomarkers for breast cancer prevention.
KW - Cancer prevention
KW - Carcinogenesis
KW - Circulating microRNAs
KW - MicroRNA transfection
KW - Sports and exercise
UR - http://www.scopus.com/inward/record.url?scp=85090283897&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090283897&partnerID=8YFLogxK
U2 - 10.18632/oncotarget.27609
DO - 10.18632/oncotarget.27609
M3 - Article
C2 - 32547708
AN - SCOPUS:85090283897
VL - 11
SP - 2106
EP - 2119
JO - Oncotarget
JF - Oncotarget
SN - 1949-2553
IS - 22
ER -